Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
11/2000
11/29/2000EP0555205B1 Dna encoding a growth factor specific for epithelial cells
11/29/2000CN1275167A Method or microbial production of amino acids of aspartate and/or glutamate family and agents which can be used in said method
11/29/2000CN1275164A Neisseria lactoferrin binding protein
11/29/2000CN1275163A Recombinant expression vector of human parathyroid hormone using phosphoribulokinase as fusion partner
11/29/2000CN1275162A Death domain containing receptor 5
11/29/2000CN1274756A L-glonate-gamma-lactonic dehydrogenase
11/29/2000CN1274751A Artificial culture of Jiuzhou caterpillar fungus and the application of its sporophore
11/29/2000CN1274701A Method for treatment of hair and feather using microbe
11/29/2000CN1274584A Application of photosynthetic bacteria as medical health article and its production process and product
11/29/2000CN1058995C Enzymatic preparation of L-carnitine
11/28/2000US6153814 Polypeptide compositions toxic to lepidopteran insects and methods for making same
11/28/2000US6153728 A protein encoded by an isolated nucleic acid molecule, the complementaray sequence of which hybridizes; producing a specific polyclonal antibodies
11/28/2000US6153423 Nucleotide sequence coding a heart polypeptide; for diagnosis, prevention, and treatment of heart, neuronal, immunological, and tumor defects; antitumor agents
11/28/2000US6153418 Enzymatic polypeptide for use in preparation of animal feeds
11/28/2000US6153417 CSAPK-1 protein and uses therefor
11/28/2000US6153406 Transforming escherichia coli cells with vector coding for protein and selectable marker, culturing in media containing glucose and selection agent, protein is expressed and found in inclusion bodies
11/28/2000US6153404 Regulatory sequence linked to sequence coding for a heterologous polypeptide; for controlled/inducible gene expression in recombinant system
11/28/2000US6153402 Death domain containing receptors
11/28/2000US6153401 Microorganisms and plasmids for 2,4-dichlorophenoxyacetic acid (2,4-D) monooxygenase formation and process for the production of these plasmids and strains
11/28/2000US6153398 Efficient method for drug screening by using recombinant auxotrophic strain that only expresses inosine 5'-monophosphate dehydrogenase from another species, applying compound to cells, and evaluating enzyme activity
11/28/2000US6153390 Isolated antigenic polypeptide from helicobacter pylori; for immunoassay diagnosis
11/28/2000US6153191 Giardia treatment and antibody
11/28/2000US6153185 Consists of an autotroph, an n-vinylcarboxylilc amide crosslinked polymer, and water to form a hydrogel aggregates
11/28/2000CA2121659C Sample processing method for mycobacteria
11/28/2000CA2091243C Recombinant acc synthase
11/28/2000CA2074681C Genetic engineering process for the production of s-(+)-2,2-dimethylcyclopropanecarboxamide by microorganisms
11/28/2000CA2066428C Structural alterations of the egf receptor gene in human gliomas
11/28/2000CA1341148C Methods and compositions for the preparation of treponema pallidum antigens, including purified antigens and dna sequences coding therefor
11/27/2000CA2309481A1 A process for the fermentative preparation of l-amino acids using coryneform bacteria
11/27/2000CA2307327A1 Process for the preparation of l-amino acids by fermentation and nucleotide sequences coding for the accda gene
11/23/2000WO2000070092A1 Expression of ets-domain proteins in cancer
11/23/2000WO2000070076A1 Tm4sf receptors
11/23/2000WO2000070060A1 Production of complex carbohydrates
11/23/2000WO2000070057A2 Mutant 1,3-propanediol dehydrogenase
11/23/2000WO2000070053A1 Transgenic plants exhibiting an altered flowering time
11/23/2000WO2000070052A1 Gene isolated from ricinus communis encoding a new protein that interacts with the oleate 12-hydroxylase enzyme
11/23/2000WO2000070051A1 NEUROPROTECTIVE PROPERTIES OF GDF-15, A NOVEL MEMBER OF THE TGF-β SUPERFAMILY
11/23/2000WO2000070049A2 Extracellular signaling molecules
11/23/2000WO2000070047A2 Full-length molecules expressed in human tissues
11/23/2000WO2000070046A2 Secreted polypeptides and corresponding polynucleotides
11/23/2000WO2000070042A1 143 human secreted proteins
11/23/2000WO2000070040A1 Cell concentration and lysate clearance using paramagnetic particles
11/23/2000WO2000070037A2 Directed evolution of microorganisms
11/23/2000WO2000070036A2 Genes expressed in hippocampus
11/23/2000WO2000070020A1 Bacteria strain lactobacillus acidophilus n.v. ep 317/402 «narine» aaa used in the production of preparations and of dietetic, therapeutic and prophylactic products for treating dysbacteriosis and the consequences thereof
11/23/2000WO2000069901A2 Proteins with insulin-like activity useful in the treatment of diabetes
11/23/2000WO2000069895A2 Bufornin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins
11/23/2000WO2000069891A2 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins
11/23/2000WO2000069888A1 Self-assembling biomolecular structures
11/23/2000WO2000069884A2 Compositions isolated from skin cells and methods for their use
11/23/2000WO2000069883A1 Methods for increasing plant cell proliferation by functionally inhibiting a plant cyclin inhibitor gene
11/23/2000WO2000069462A1 Human monoclonal antibody
11/23/2000WO2000054584B1 Method of preparing cryogenically preserved adherent cell containing plate for tissue culture applications
11/23/2000WO2000046375A3 Methods for producing polypeptides in fungal cells
11/23/2000WO2000043410A3 Novel odorant receptors in drosophila
11/23/2000WO2000042560A3 Methods for making character strings, polynucleotides and polypeptides
11/23/2000WO2000037685A9 Method of identifying a psychotropic agent using differential gene expression
11/23/2000WO2000037608A3 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto
11/23/2000WO2000036124A3 Plant cell cycle genes and uses thereof
11/23/2000WO2000036092A3 METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-β RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION
11/23/2000WO2000032221A3 Promotion or inhibition of angiogenesis and cardiovascularization
11/23/2000WO2000027994A3 Chlamydia pneumoniae genome sequence
11/23/2000WO2000027429A3 Vaccine against papillomatous digital dermatitis (pdd)
11/23/2000WO2000026348A3 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity
11/23/2000WO2000022144A3 Means and methods for modulating stomata characteristica in plants
11/23/2000WO2000020450A3 Calcium channel alpha-2/delta gene
11/23/2000WO2000017369A3 Alzheimer's disease secretase
11/23/2000WO2000015666A3 Compositions and methods for the treatment of tumors
11/23/2000WO2000007545A3 Apoptosis proteins
11/23/2000WO1999004775A3 Method of treating dopaminergic and gaba-nergic disorders
11/23/2000DE19919124A1 Nukleinsäuremolekül, umfassend eine für ein Polypeptid mit Chorismatmutase-Aktivität kodierende Nukleinsäure Nucleic acid molecule comprising a sequence encoding a polypeptide having chorismate mutase activity nucleic acid
11/23/2000CA2374235A1 Production of complex carbohydrates
11/23/2000CA2374053A1 Secreted polypeptides and corresponding polynucleotides
11/23/2000CA2374045A1 Compositions isolated from skin cells and methods for their use
11/23/2000CA2374015A1 Gene isolated from ricinus communis encoding a new protein that interacts with the oleate 12-hydroxylase enzyme
11/23/2000CA2373616A1 Tm4sf receptors
11/23/2000CA2373231A1 Extracellular signaling molecules
11/23/2000CA2373191A1 Full-length molecules expressed in human tissues
11/23/2000CA2372926A1 143 human secreted proteins
11/23/2000CA2372556A1 Directed evolution of microorganisms
11/23/2000CA2372485A1 Cell concentration and lysate clearance using paramagnetic particles
11/23/2000CA2372393A1 Novel proteins with insulin-like activity useful in the treatment of diabetes
11/23/2000CA2372323A1 Methods for increasing plant cell proliferation by functionally inhibiting a plant cyclin inhibitor gene
11/23/2000CA2372304A1 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins
11/23/2000CA2372200A1 Self-assembling biomolecular structures
11/23/2000CA2372119A1 Neuroprotective properties of gdf-15, a novel member of the tgf-.beta. superfamily
11/23/2000CA2369369A1 Buforin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins
11/23/2000CA2368833A1 Molecules expressed in hippocampus
11/22/2000EP1054063A2 Process for the production of naturally folded and secreted proteins
11/22/2000EP1054062A1 Glycosyltransferase and dna encoding the same
11/22/2000EP1054059A1 Novel cDNAs encoding catenin-binding proteins with function in signalling and/or gene regulation
11/22/2000EP1054057A1 Mutagenesis method
11/22/2000EP1053474A1 Method for the determination of prosthetic infections
11/22/2000EP1053351A1 Novel molecules of the tnf receptor superfamily and uses therefor
11/22/2000EP1053344A1 Mortierella
11/22/2000EP1053335A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
11/22/2000EP1053333A1 Single-chain polypeptides comprising creatine kinase m and creatine kinase b
11/22/2000EP1053332A1 Protein
11/22/2000EP1053331A2 A novel fungal protein critical for expression of fungal proteins
11/22/2000EP1053325A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination